Gitto Stefano, Fiorillo Claudia, Argento Flavia Rita, Fini Eleonora, Borghi Serena, Falcini Margherita, Roccarina Davide, La Delfa Rosario, Lillo Ludovica, Zurli Tommaso, Forte Paolo, Ghinolfi Davide, De Simone Paolo, Chiesi Francesca, Ingravallo Angelica, Vizzutti Francesco, Aspite Silvia, Laffi Giacomo, Lynch Erica, Petruccelli Stefania, Carrai Paola, Palladino Simona, Sofi Francesco, Stefani Laura, Amedei Amedeo, Baldi Simone, Toscano Arianna, Lau Chloe, Marra Fabio, Becatti Matteo
Internal Medicine and Liver Unit, University Hospital Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Department of Experimental and Clinical Biomedical Sciences "Mario Serio," University of Florence, Florence, Italy.
Res Pract Thromb Haemost. 2024 Aug 23;8(6):102555. doi: 10.1016/j.rpth.2024.102555. eCollection 2024 Aug.
Cardiovascular events represent a major cause of non-graft-related death after liver transplant. Evidence suggest that chronic inflammation associated with a remarkable oxidative stress in the presence of endothelial dysfunction and procoagulant environment plays a major role in the promotion of thrombosis. However, the underlying molecular mechanisms are not completely understood.
In order to elucidate the mechanisms of posttransplant thrombosis, the aim of the present study was to investigate the role of oxidation-induced structural and functional fibrinogen modifications in liver transplant recipients.
A case-control study was conducted on 40 clinically stable liver transplant recipients and 40 age-matched, sex-matched, and risk factor-matched controls. Leukocyte reactive oxygen species (ROS) production, lipid peroxidation, glutathione content, plasma antioxidant capacity, fibrinogen oxidation, and fibrinogen structural and functional features were compared between patients and controls.
Patients displayed enhanced leukocyte ROS production and an increased plasma lipid peroxidation with a reduced total antioxidant capacity compared with controls. This systemic oxidative stress was associated with fibrinogen oxidation with fibrinogen structural alterations. Thrombin-catalyzed fibrin polymerization and fibrin resistance to plasmin-induced lysis were significantly altered in patients compared with controls. Moreover, steatotic graft and smoking habit were associated with high fibrin degradation rate.
ROS-induced fibrinogen structural changes might increase the risk of thrombosis in liver transplant recipients.
心血管事件是肝移植后非移植物相关死亡的主要原因。有证据表明,在内皮功能障碍和促凝环境存在的情况下,与显著氧化应激相关的慢性炎症在血栓形成的促进中起主要作用。然而,其潜在的分子机制尚未完全了解。
为了阐明移植后血栓形成的机制,本研究旨在探讨氧化诱导的纤维蛋白原结构和功能改变在肝移植受者中的作用。
对40例临床稳定的肝移植受者和40例年龄、性别及危险因素匹配的对照者进行病例对照研究。比较患者和对照者的白细胞活性氧(ROS)生成、脂质过氧化、谷胱甘肽含量、血浆抗氧化能力、纤维蛋白原氧化以及纤维蛋白原的结构和功能特征。
与对照者相比,患者表现出白细胞ROS生成增加、血浆脂质过氧化增加以及总抗氧化能力降低。这种全身性氧化应激与纤维蛋白原氧化及纤维蛋白原结构改变有关。与对照者相比,患者凝血酶催化的纤维蛋白聚合以及纤维蛋白对纤溶酶诱导溶解的抵抗能力显著改变。此外,脂肪变性移植物和吸烟习惯与高纤维蛋白降解率相关。
ROS诱导的纤维蛋白原结构改变可能增加肝移植受者的血栓形成风险。